Thu, May 11, 2017
Wed, May 10, 2017

Jessica Fye Initiated (ASND) at Buy and Held Target at $36 on, May 11th, 2017

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-36-on-may-11th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Jessica Fye of JP Morgan, Initiated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $36 on, May 11th, 2017.

Jessica has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 1 agrees with Jessica's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joseph Schwartz of "Leerink Swann" Downgraded from Buy to Hold and Increased Target to $30 on, Thursday, March 9th, 2017


These are the ratings of the 2 analyists that currently disagree with Jessica


  • Liana Moussatos of "Wedbush" Reiterated at Buy with Increased Target to $34 on, Friday, March 24th, 2017
  • Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $28 on, Thursday, February 9th, 2017